MAPT and Alzheimer disease: Scientists have found that many pathological processes, for instance, neural inflammation (Leng and Edison, 2021), oxidative stress (Song et al., 2021) and metal dysregulation (Wang et al., 2020; Aaseth et al., 2021), involved in Aβ deposition and tau hyperphosphorylation, driving the insidious progression before AD diagnosis.